Enzalutamide

What is Enzalutamide?

Enzalutamide is a groundbreaking medication primarily used in the treatment of advanced prostate cancer. It belongs to a class of drugs known as androgen receptor inhibitors. Marketed under the brand name Xtandi, this oral medication works by targeting the androgen receptor signaling pathway, which is crucial for the growth and survival of prostate cancer cells. Unlike traditional chemotherapy, Enzalutamide is a form of targeted hormone therapy, offering a different mechanism of action to combat the disease. It has significantly improved outcomes for patients with various stages of prostate cancer, particularly those who have become resistant to standard hormone treatments.

How Does it Work?

Prostate cancer often relies on male hormones, known as androgens (like testosterone), to grow. These hormones bind to androgen receptors within cancer cells, stimulating their proliferation. Enzalutamide works by interfering with this process at multiple levels:

• Inhibiting Androgen Binding: It prevents androgens from binding to androgen receptors on prostate cancer cells.
• Impacting Receptor Translocation: It stops the androgen receptor from moving into the cell nucleus, where it would typically interact with DNA to promote cancer cell growth.
• Preventing DNA Binding: It impairs the androgen receptor's ability to bind to DNA, thus blocking the transcription of genes that support cancer cell survival and proliferation.

By disrupting the androgen receptor signaling pathway, Enzalutamide effectively starves the cancer cells of the necessary signals for growth, leading to their death or inhibition of their spread. This multi-faceted approach makes it a powerful agent in managing hormone-sensitive and castration-resistant forms of the disease.

Medical Uses

Enzalutamide is approved for the treatment of several forms of prostate cancer:

• Metastatic Castration-Resistant Prostate Cancer (mCRPC): This is prostate cancer that has spread to other parts of the body and continues to grow despite medical or surgical castration (lowering testosterone levels). Enzalutamide has been shown to improve overall survival in these patients, both before and after chemotherapy.
• Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC): For patients whose cancer has not yet spread but is progressing despite castration, Enzalutamide can delay the onset of metastases.
• Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): This refers to prostate cancer that has spread but still responds to hormone therapy. Enzalutamide, in combination with androgen deprivation therapy (ADT), is used as an initial treatment to improve survival and delay disease progression.

Its broad utility across different stages of advanced prostate cancer underscores its significance as a therapeutic option.

Dosage

The standard recommended dose of Enzalutamide is 160 mg (four 40 mg capsules or two 80 mg tablets) taken orally once daily. It can be taken with or without food. Patients should swallow the capsules or tablets whole and not chew, crush, or open them. It is crucial to continue concurrent androgen deprivation therapy (ADT) with a GnRH analogue or to have had a bilateral orchiectomy during treatment with Enzalutamide.

If a dose is missed, patients should take their prescribed dose at the next scheduled time. They should not take a double dose to make up for a missed dose. Dose adjustments may be necessary based on individual tolerability and in cases of certain drug interactions, or if specific side effects occur, always under the guidance of a healthcare professional.

Side Effects

Like all medications, Enzalutamide can cause side effects. Common side effects often include:

• Fatigue or asthenia (weakness)
• Hot flashes
• Decreased appetite
• Diarrhea or constipation
• Joint pain or back pain
• Headache
• Hypertension (high blood pressure)

More serious, though less common, side effects can include:

• Seizures: This is a rare but significant side effect. Patients with a history of seizures or predisposing factors may be at higher risk.
• Posterior Reversible Encephalopathy Syndrome (PRES): A rare neurological disorder characterized by headache, confusion, seizures, and visual disturbances.
• Cardiovascular Events: Including ischemic heart disease, heart failure, and stroke.
• Falls and Fractures: Increased risk, particularly in elderly patients.

Patients should report any new or worsening symptoms to their doctor immediately. A healthcare provider can assess the severity of side effects and recommend appropriate management strategies.

Drug Interactions

Enzalutamide is a potent inducer of several enzymes, particularly cytochrome P450 (CYP) enzymes, including CYP3A4 and CYP2C8, and to a lesser extent, CYP2C9. This means it can significantly alter the metabolism of other drugs, potentially reducing their effectiveness or increasing their toxicity. Key interactions to be aware of include:

• CYP3A4 Substrates: Enzalutamide can decrease the concentrations of drugs metabolized by CYP3A4, such as certain opioids (e.g., fentanyl), immunosuppressants (e.g., tacrolimus), antiarrhythmics (e.g., amiodarone), and statins (e.g., simvastatin). Dose adjustments for these medications may be necessary.
• CYP2C8 Substrates: Drugs like warfarin (an anticoagulant) and repaglinide (for diabetes) may have their effects altered. Increased monitoring of INR for warfarin users is crucial.
• CYP2C9 Substrates: While less pronounced, interactions with drugs like celecoxib or phenytoin are possible.
• Strong CYP2C8 and CYP3A4 Inhibitors/Inducers: Concomitant use with strong inhibitors (e.g., gemfibrozil, itraconazole, clarithromycin) can increase Enzalutamide exposure, while strong inducers (e.g., rifampin, phenytoin, carbamazepine) can decrease its effectiveness.

Patients must inform their doctor about all medications, supplements, and herbal products they are taking to avoid potentially dangerous interactions.

FAQ

Is Enzalutamide chemotherapy?

No, Enzalutamide is not chemotherapy. It is a type of targeted hormone therapy classified as an androgen receptor inhibitor. It works by blocking the effects of male hormones that fuel prostate cancer growth, rather than directly killing rapidly dividing cells like chemotherapy.

How long do I need to take Enzalutamide?

Enzalutamide is typically taken long-term, as long as the treatment is beneficial and the side effects are manageable. Your doctor will regularly monitor your condition to determine the optimal duration of treatment.

Can Enzalutamide cure prostate cancer?

While Enzalutamide can significantly control the progression of advanced prostate cancer, extend life, and improve quality of life, it is generally not considered a cure for metastatic disease. It helps manage the cancer, often for many years.

What is the difference between Enzalutamide and abiraterone?

Both Enzalutamide and abiraterone are used to treat advanced prostate cancer, but they work differently. Abiraterone (Zytiga) inhibits an enzyme called CYP17, which is involved in androgen production, thereby reducing the amount of male hormones in the body. Enzalutamide directly blocks the androgen receptor on cancer cells, preventing them from receiving growth signals.

Products containing Enzalutamide are available through trusted online pharmacies. You can browse Enzalutamide-based medications at ShipperVIP or Medicenter.

Summary

Enzalutamide represents a significant advancement in the treatment of various stages of advanced prostate cancer. As a potent androgen receptor inhibitor, it offers a targeted hormone therapy approach that has demonstrated improved survival rates and delayed disease progression for patients with castration-resistant and metastatic forms of the disease. While generally well-tolerated, it is crucial for patients to be aware of potential side effects, including the rare risk of seizures, and to discuss all existing medications with their healthcare provider due to potential drug interactions. Through its unique mechanism of action, Enzalutamide continues to be a cornerstone in the comprehensive management of this complex disease, offering hope and extended life to many patients.